Oncology & Cell Fate Peptides are essential research tools used to study cancer biology, tumor progression, and cellular decision-making. This category includes highly specific peptides such as RGD Peptide, BH3 Peptides, and iRGD, which are widely used in cancer laboratories worldwide.

These peptides support research into targeted cancer therapies, apoptosis induction, tumor microenvironment modulation, and cell fate control (proliferation, differentiation, and programmed cell death).

Popular Products in This Category:

– **RGD Peptide** – Classic tumor-homing and integrin-targeting peptide

– **BH3 Peptides** – Apoptosis-inducing peptides targeting Bcl-2 family proteins

– **iRGD Peptide** – Advanced tumor-penetrating peptide for enhanced delivery

**Key Research Applications:**

– Tumor targeting and imaging

– Induction of cancer cell apoptosis (especially with BH3 peptides)

– Integrin-mediated tumor homing (**RGD** and **iRGD**)

– Cell cycle regulation and proliferation studies

– Development of peptide-drug conjugates (PDCs)

### **Benefits of Our Oncology & Cell Fate Peptides**

– ≥98% purity (HPLC & MS verified)

– Includes popular sequences like **RGD**, **cRGDfK**, **BH3 domain peptides**, and **iRGD**

– Linear, cyclic, and modified versions available

– Strict research use only

 **Sample FAQ Section**

**What is RGD Peptide used for in oncology?**

RGD Peptide is widely used for tumor targeting as it binds to αvβ3 integrins overexpressed on cancer cells and tumor vasculature.

**What are BH3 Peptides?**

BH3 Peptides are pro-apoptotic peptides that mimic the BH3 domain to inhibit anti-apoptotic proteins (like Mcl-1 and Bcl-2), helping trigger cancer cell death in research.

**What makes iRGD Peptide special?**

iRGD is a tumor-penetrating peptide that not only targets integrins but also enhances tissue penetration and drug delivery into solid tumors.